Speakers
Dr Lucy Harper
Event Essentials
Dr Lucy Harper is the Chief Executive of Applied Microbiology International (AMI), where she plays a pivotal role in promoting the importance of microbiology in addressing global challenges. Dr Harper's leadership at AMI has been instrumental in initiating programmes that connect scientific research with real-world applications, thus advancing the field of microbiology.
Dr Thomas Willmott is a Postdoctoral Research Associate in Clinical Infection, Microbiology & Immunology at the University of Liverpool. He conducts research primarily focusing on microbiome studies, polymicrobial in vitro modelling, and antimicrobial resistance. In his role at the Microbiome Innovation Centre, Dr Willmott's research examines how oral bacteria influence systemic diseases, such as cardiovascular disease, immune system responses, and metabolic disorders. His recent work investigates the oral microbiome's role in chronic kidney disease and post-transplant outcomes, offering insights into how these microbial communities affect overall health.
His studies contribute to understanding microbial interactions and their potential implications for developing new treatments that target these dynamics to improve health outcomes. Dr. Willmott’s research is instrumental in advancing knowledge on the connection between localized microbiota and broader systemic effects.